First CAR T-Cell Therapy Approved in Pediatric, Young Adult ALL – www.oncnursingnews.com/
www.oncnursingnews.com/ |
First CAR T-Cell Therapy Approved in Pediatric, Young Adult ALL
www.oncnursingnews.com/ The FDA issued a historic approval of the first Chimeric Antigen Receptor (CAR) T-Cell Therapy, authorizing the use of tisagenlecleucel (Kymriah) for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia … |
